glp 1 agonist drugs GLP-1 Agonists Examples: Which One Wins? Holding GLP-1 Agonists Prior to

A newly published clinical investigation in the British Journal of Anaesthesia (May 2025 issue) reveals compelling evidence linking glucagon-like peptide-1 receptor agonists (GLP-1RAs) to impaired gastric emptying (IGE)

Demand for these drugs has increased rapidly in recent years, as indications have expanded, but they remain expensive

Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management

Purpose of the Review Glucagon-like peptide 1 (GLP-1) receptor agonists (RA) have transformed obesity and type 2 diabetes (T2D) management

Here, we provide a comprehensive review of the therapeutic potential of incretin mimetics and insulin in AD and PD.

Those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting drunk compared to those who didn't take the medication, the study found.